NurExone Biologic announces annual general and special shareholder meeting
- NurExone Biologic will hold its annual general and special shareholder meeting in Toronto on Sept. 15, 2026.
- Shareholders will vote on electing five directors for the coming year.
- Ballot also covers reappointing Ziv Haft, CPA (Isr.), a BDO member firm, as auditor.
- Disinterested shareholders will vote on reapproving the amended and restated omnibus equity incentive plan.
- Special resolution seeks authority to consolidate shares by up to 30 pre-consolidation shares for 1 post-consolidation share within 36 months.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NurExone Biologic Inc. published the original content used to generate this news brief on August 19, 2026, and is solely responsible for the information contained therein.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Trade now！
You may also like
Crypto prices
More
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now